506 related articles for article (PubMed ID: 14728016)
1. Transfusion medicine : support of patients undergoing cardiac surgery.
Goodnough LT; Despotis GJ
Am J Cardiovasc Drugs; 2001; 1(5):337-51. PubMed ID: 14728016
[TBL] [Abstract][Full Text] [Related]
2. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
3. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
[TBL] [Abstract][Full Text] [Related]
4. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators.
Fergusson D; Blair A; Henry D; Hisashige A; Huet C; Koopman-van Gemert A; Katz E; McClelland B; Sigmund H; Laupacis A
Int J Technol Assess Health Care; 1999; 15(4):717-28. PubMed ID: 10645113
[TBL] [Abstract][Full Text] [Related]
5. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.
; Ferraris VA; Ferraris SP; Saha SP; Hessel EA; Haan CK; Royston BD; Bridges CR; Higgins RS; Despotis G; Brown JR; ; Spiess BD; Shore-Lesserson L; Stafford-Smith M; Mazer CD; Bennett-Guerrero E; Hill SE; Body S
Ann Thorac Surg; 2007 May; 83(5 Suppl):S27-86. PubMed ID: 17462454
[TBL] [Abstract][Full Text] [Related]
6. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of interventions for minimizing perioperative blood transfusion for surgery for craniosynostosis.
White N; Bayliss S; Moore D
J Craniofac Surg; 2015 Jan; 26(1):26-36. PubMed ID: 25569385
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.
Porte RJ; Leebeek FW
Drugs; 2002; 62(15):2193-211. PubMed ID: 12381219
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model.
Davies L; Brown TJ; Haynes S; Payne K; Elliott RA; McCollum C
Health Technol Assess; 2006 Nov; 10(44):iii-iv, ix-x, 1-210. PubMed ID: 17049141
[TBL] [Abstract][Full Text] [Related]
11. Conservation of blood during cardiovascular surgery.
Cooley DA
Am J Surg; 1995 Dec; 170(6A Suppl):53S-59S. PubMed ID: 8546249
[TBL] [Abstract][Full Text] [Related]
12. Reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery.
Tse EY; Cheung WY; Ng KF; Luk KD
J Bone Joint Surg Am; 2011 Jul; 93(13):1268-77. PubMed ID: 21776581
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative autologous blood salvage with cardiac surgery: an analysis of five years' experience in more than 3,000 patients.
Ikeda S; Johnston MF; Yagi K; Gillespie KN; Schweiss JF; Homan SM
J Clin Anesth; 1992; 4(5):359-66. PubMed ID: 1389188
[TBL] [Abstract][Full Text] [Related]
14. Spine tumor resection among patients who refuse blood product transfusion: a retrospective case series.
Kisilevsky AE; Stobart L; Roland K; Flexman AM
J Clin Anesth; 2016 Dec; 35():434-440. PubMed ID: 27871571
[TBL] [Abstract][Full Text] [Related]
15. Perioperative management of four anaemic female Jehovah's Witnesses undergoing urgent complex cardiac surgery.
Casati V; D'Angelo A; Barbato L; Turolla D; Villa F; Grasso MA; Porta A; Guerra F
Br J Anaesth; 2007 Sep; 99(3):349-52. PubMed ID: 17596592
[TBL] [Abstract][Full Text] [Related]
16. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique.
Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW
J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative hemodilution and autologous platelet rich plasma collection: two techniques for collecting fresh autologous blood.
Triulzi DJ; Ness PM
Transfus Sci; 1995 Mar; 16(1):33-44. PubMed ID: 10172465
[TBL] [Abstract][Full Text] [Related]
18. Perioperative blood conservation.
Cardone D; Klein AA
Eur J Anaesthesiol; 2009 Sep; 26(9):722-9. PubMed ID: 19448549
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietic therapy: cost efficiency and reimbursement.
Jaspan D
Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S19-29. PubMed ID: 17687067
[TBL] [Abstract][Full Text] [Related]
20. Jehovah's Witnesses and cardiac surgery: a single institution's experience.
McCartney S; Guinn N; Roberson R; Broomer B; White W; Hill S
Transfusion; 2014 Oct; 54(10 Pt 2):2745-52. PubMed ID: 24809815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
